IMMUNICOM, INC.
Medtech · Private
Subtractive immunopheresis column device that removes circulating soluble TNF-α receptors to enhance innate immune response against solid tumors
- Grants
- $1.1M
- 1 award
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 36
- 5 granted · 31 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20212022
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase II · Evaluation of Subtractive Immunopheresis for Treatment of Hormone-Refractive Advanced Breast Cancer | $1,072,330 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2136 | OCUVERA LLC | — | — |
| 2137 | RESTOREAR DEVICES LLC | — | — |
| 2138 | WI-SENSE LLC | — | — |
| 2139 | IMMUNICOM, INC. | — | — |
| 2140 | Embark Medical | — | — |
| 2141 | Iasis Molecular Sciences INC. | — | — |
| 2142 | VESAREX LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Modified Tnf As A Capture Ligandapplication
- Modified Tnf As A Capture Ligandgranted
- Increasing Responses To Checkpoint Inhibitors By Extracorporeal Apheresisapplication
- Increasing Responses To Checkpoint Inhibitors By Extracorporeal Apheresisgranted
- Reduced Leaching Of A Ligandapplication
- Reduced Leaching Of A Ligandgranted
- System And Method For Removal Of Immune Inhibitors From Biological Fluidsapplication
- System And Method For Removal Of Immune Inhibitors From Biological Fluidsapplication
- Augmentation Of Personalized Tumor Specific Adaptive Immunity Through Extracorporeal Removal Of Immune Blocking Factorsapplication
- Reduced Leaching Of A Ligandapplication
- System And Method For Removal Of Immune Inhibitors From Biological Fluidsapplication
- System And Method For Removal Of Immune Inhibitors From Biological Fluidsapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.